Michael Andreeff

74.1k total citations · 12 hit papers
1.0k papers, 48.1k citations indexed

About

Michael Andreeff is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Michael Andreeff has authored 1.0k papers receiving a total of 48.1k indexed citations (citations by other indexed papers that have themselves been cited), including 538 papers in Molecular Biology, 505 papers in Hematology and 281 papers in Oncology. Recurrent topics in Michael Andreeff's work include Acute Myeloid Leukemia Research (413 papers), Chronic Lymphocytic Leukemia Research (134 papers) and Chronic Myeloid Leukemia Treatments (126 papers). Michael Andreeff is often cited by papers focused on Acute Myeloid Leukemia Research (413 papers), Chronic Lymphocytic Leukemia Research (134 papers) and Chronic Myeloid Leukemia Treatments (126 papers). Michael Andreeff collaborates with scholars based in United States, Japan and Germany. Michael Andreeff's co-authors include Marina Konopleva, Hagop M. Kantarjian, Frank C. Marini, Steven M. Kornblau, Erika L. Spaeth, Jörge E. Cortes, Ismael Samudio, Ann H. Klopp, Teresa McQueen and Jennifer L. Dembinski and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael Andreeff

978 papers receiving 47.2k citations

Hit Papers

Differentiation Therapy of Acute Promyelocytic Leukemia w... 1984 2026 1998 2012 1991 2005 2002 2005 2009 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
    1991 1.1k citations Michael Andreeff et al. profile →
  2. Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
    2005 869 citations Frank C. Marini, Michael Andreeff et al. Cancer Research profile →
  3. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.
    2002 768 citations Frank C. Marini, Michael Andreeff et al. profile →
  4. Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
    2005 704 citations Michael Andreeff, Jörge E. Cortes et al. profile →
  5. Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression
    2009 653 citations Erika L. Spaeth, Ann H. Klopp et al. profile →
  6. Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia
    2000 586 citations Hagop M. Kantarjian, Jörge E. Cortes et al. profile →
  7. Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging
    2009 554 citations Erika L. Spaeth, Ann H. Klopp et al. profile →
  8. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
    2009 552 citations Ismael Samudio, Michael Fiegl et al. Journal of Clinical Investigation profile →
  9. Convention on nomenclature for DNA cytometry
    1984 538 citations Michael Andreeff et al. profile →
  10. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.
    2000 518 citations Steven M. Kornblau, Michael Andreeff et al. profile →
  11. Bone marrow niches in haematological malignancies
    2020 305 citations Michael Andreeff et al. profile →
  12. MDM2 inhibition: an important step forward in cancer therapy
    2020 276 citations Marina Konopleva, Michael Andreeff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Andreeff United States 112 25.9k 16.0k 13.6k 10.3k 7.3k 1.0k 48.1k
Francis J. Giles United States 105 15.0k 0.6× 20.4k 1.3× 9.3k 0.7× 15.8k 1.5× 2.8k 0.4× 786 41.9k
Charles L. Sawyers United States 99 24.8k 1.0× 15.8k 1.0× 12.3k 0.9× 11.6k 1.1× 9.3k 1.3× 266 53.4k
Brian Druker United States 106 17.1k 0.7× 30.5k 1.9× 10.9k 0.8× 21.7k 2.1× 3.2k 0.4× 607 54.8k
Guillermo Garcia‐Manero United States 106 17.8k 0.7× 30.6k 1.9× 7.5k 0.6× 14.7k 1.4× 2.8k 0.4× 1.5k 44.1k
Bob Löwenberg Netherlands 89 14.3k 0.6× 23.5k 1.5× 8.0k 0.6× 5.9k 0.6× 2.8k 0.4× 534 35.9k
Pier Giuseppe Pelicci Italy 106 31.6k 1.2× 9.5k 0.6× 9.6k 0.7× 2.9k 0.3× 3.9k 0.5× 532 45.6k
Elihu H. Estey United States 100 16.0k 0.6× 27.6k 1.7× 8.6k 0.6× 8.7k 0.8× 2.4k 0.3× 687 39.7k
Marina Konopleva United States 94 15.8k 0.6× 15.6k 1.0× 7.9k 0.6× 5.9k 0.6× 3.4k 0.5× 917 30.5k
Paul G. Richardson United States 116 33.9k 1.3× 32.3k 2.0× 22.5k 1.7× 4.6k 0.4× 3.4k 0.5× 1.1k 51.8k
Nikhil C. Munshi United States 106 25.2k 1.0× 21.5k 1.3× 16.7k 1.2× 3.6k 0.3× 3.8k 0.5× 799 40.1k

Countries citing papers authored by Michael Andreeff

Since Specialization
Citations

This map shows the geographic impact of Michael Andreeff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Andreeff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Andreeff more than expected).

Fields of papers citing papers by Michael Andreeff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Andreeff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Andreeff. The network helps show where Michael Andreeff may publish in the future.

Co-authorship network of co-authors of Michael Andreeff

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Andreeff. A scholar is included among the top collaborators of Michael Andreeff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Andreeff. Michael Andreeff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anand, Vivek, Natalia Baran, Zheng Yin, et al.. (2025). GD3 synthase drives resistance to p53-induced apoptosis in breast cancer by modulating mitochondrial function. Oncogene. 44(30). 2646–2661. 2 indexed citations
2.
Ayoub, Edward, Li Li, Muharrem Müftüoğlu, et al.. (2024). Single-Cell Multiomics Unveils Venetoclax-Resistant Monocytic Differentiation and Immune Evasion in TP53 Mutant AML Clones. Blood. 144(Supplement 1). 61–61. 2 indexed citations
3.
Carter, Bing Z., Po Yee Mak, Wenjing Tao, et al.. (2022). Maximal Activation of Apoptosis Signaling by Cotargeting Antiapoptotic Proteins in BH3 Mimetic–Resistant AML and AML Stem Cells. Molecular Cancer Therapeutics. 21(6). 879–889. 11 indexed citations
4.
Piya, Sujan, Hong Mu, Seemana Bhattacharya, et al.. (2019). BETP degradation simultaneously targets acute myelogenous leukemic stem cells and the microenvironment. Journal of Clinical Investigation. 129(5). 1878–1894. 56 indexed citations
5.
Jiang, Xuejie, Po Yee Mak, Hong Mu, et al.. (2018). Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in FLT3 -Mutant Acute Myeloid Leukemia. Clinical Cancer Research. 24(10). 2417–2429. 67 indexed citations
6.
Carter, Bing Z., Po Yee Mak, Xiangmeng Wang, et al.. (2017). Focal Adhesion Kinase as a Potential Target in AML and MDS. Molecular Cancer Therapeutics. 16(6). 1133–1144. 31 indexed citations
7.
Zhou, Fuling, Yunbao Pan, Yongchang Wei, et al.. (2017). Jab1/Csn5–Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress. Clinical Cancer Research. 23(15). 4450–4461. 52 indexed citations
8.
Zhang, Weiguo, Gautam Borthakur, Gao Chen, et al.. (2016). The Dual MEK/FLT3 Inhibitor E6201 Exerts Cytotoxic Activity against Acute Myeloid Leukemia Cells Harboring Resistance-Conferring FLT3 Mutations. Cancer Research. 76(6). 1528–1537. 52 indexed citations
9.
Pan, Rongqing, Vivian Ruvolo, Jun Wei, et al.. (2015). Inhibition of Mcl-1 with the pan–Bcl-2 family inhibitor (–)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia. Blood. 126(3). 363–372. 111 indexed citations
10.
Konopleva, Marina, Roland B. Walter, Stefan Faderl, et al.. (2014). Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia. Clinical Cancer Research. 20(8). 2226–2235. 70 indexed citations
11.
Zhang, Weiguo, Vivian Ruvolo, Gao Chen, et al.. (2014). Evaluation of Apoptosis Induction by Concomitant Inhibition of MEK, mTOR, and Bcl-2 in Human Acute Myelogenous Leukemia Cells. Molecular Cancer Therapeutics. 13(7). 1848–1859. 30 indexed citations
12.
Spaeth, Erika L., Adam M. LaBaff, Bryan P. Toole, et al.. (2013). Mesenchymal CD44 Expression Contributes to the Acquisition of an Activated Fibroblast Phenotype via TWIST Activation in the Tumor Microenvironment. Cancer Research. 73(17). 5347–5359. 74 indexed citations
13.
Pierceall, William E., Steven M. Kornblau, Nicole E. Carlson, et al.. (2013). BH3 Profiling Discriminates Response to Cytarabine-Based Treatment of Acute Myelogenous Leukemia. Molecular Cancer Therapeutics. 12(12). 2940–2949. 22 indexed citations
14.
Klopp, Ann H., Yan Zhang, Travis Solley, et al.. (2011). Omental Adipose Tissue–Derived Stromal Cells Promote Vascularization and Growth of Endometrial Tumors. Clinical Cancer Research. 18(3). 771–782. 143 indexed citations
15.
16.
Samudio, Ismael, Michael Fiegl, Teresa McQueen, Karen Clise-Dwyer, & Michael Andreeff. (2008). The Warburg Effect in Leukemia-Stroma Cocultures Is Mediated by Mitochondrial Uncoupling Associated with Uncoupling Protein 2 Activation. Cancer Research. 68(13). 5198–5205. 136 indexed citations
17.
Konopleva, Marina, Julie C. Watt, Rooha Contractor, et al.. (2008). Mechanisms of Antileukemic Activity of the Novel Bcl-2 Homology Domain-3 Mimetic GX15-070 (Obatoclax). Cancer Research. 68(9). 3413–3420. 215 indexed citations
18.
Tabe, Yoko, Linhua Jin, Yuko Tsutsumi‐Ishii, et al.. (2007). Activation of Integrin-Linked Kinase Is a Critical Prosurvival Pathway Induced in Leukemic Cells by Bone Marrow–Derived Stromal Cells. Cancer Research. 67(2). 684–694. 154 indexed citations
19.
Konopleva, Marina, Rooha Contractor, Peter P. Ruvolo, et al.. (2006). Mechanism of apoptosis induction by chemical inhibitors of bcl-2 in acute leukemia cells. Cancer Research. 66. 1142–1143. 2 indexed citations
20.
Andreeff, Michael, G Wong, & Benjamín Koziner. (1985). Non B- non T acute lymphoblastic leukemia (ALL): Evidence for complete B cell differentiation of a quiescent subpopulation and their response to induction therapy. Proceedings of the American Association for Cancer Research. 26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis J. Giles Breakdown of academic impact, for papers by Charles L. Sawyers Breakdown of academic impact, for papers by Brian Druker Breakdown of academic impact, for papers by Guillermo Garcia‐Manero Breakdown of academic impact, for papers by Bob Löwenberg Breakdown of academic impact, for papers by Pier Giuseppe Pelicci Breakdown of academic impact, for papers by Elihu H. Estey Breakdown of academic impact, for papers by Marina Konopleva Breakdown of academic impact, for papers by Paul G. Richardson Breakdown of academic impact, for papers by Nikhil C. Munshi
Rankless by CCL
2026